Conference themes
Advance Life-Changing Therapies for Adolescents and Adults With Rare Neurological Disorders
Welcome to the 1st Rare and Genetic Neurodegenerative Drug Development Summit! This trailblazing meeting will be discussing, debating and exploring pivotal rare and genetic neurodegenerative disease research making industry news headlines.
Pioneers in this exclusive industry are convening online, this June, to network and learn from experts in pharma, biotech and academia.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Anka G. Ehrhardt, Director, Cell-Based Assays / Analytical Research and Development, Merck, Christopher Missling, President and Chief, Executive Officer, Anavex Life Sciences, David Theron, Development Director in Neurology, Servier & more
Enquiries and Registration:
https://go.evvnt.com/1056250-2?pid=4832
Mr. Hanson Wade
CategoriesGeneral Medicine